West Pharmaceutical Services, Inc. logo
WSTWest Pharmaceutical Services, Inc.

Price/FCF Ratio: 55.46

Is the Price/FCF ratio high or low?

The Price/FCF ratio of 55.46 is 16% below its 5-year average of 65.65, near the low end of its 5-year range (35.83–123.39).

8.78% above its 12-month average of 50.99.

WST Price/FCF Ratio

WST Price/FCF Ratio Chart

55.46
+6.47% 1Y
WST Price/FCF Ratio

WST Average Price/FCF Ratio Chart

WST Price/FCF Ratio

WST Current vs Average Price/FCF Ratio Chart

WST Price/FCF Ratio Metrics

PRICE/FCF RATIO

55.46

PRICE/FCF RATIO AVG TTM

50.99

PRICE/FCF RATIO AVG 3Y

60.14

PRICE/FCF RATIO AVG 5Y

62.91

PRICE/FCF RATIO AVG 10Y

64.97

PRICE/FCF RATIO AVG 15Y

60.83

PRICE/FCF RATIO AVG 20Y

57.04

CURRENT VS TTM AVG

+8.78%

CURRENT VS 3Y AVG

-7.79%

CURRENT VS 5Y AVG

-11.84%

CURRENT VS 10Y AVG

-14.63%

CURRENT VS 15Y AVG

-8.82%

CURRENT VS 20Y AVG

-2.77%

WST Competitors' Price/FCF Ratio

NAMEMARKET CAPPRICE/FCF RATIOTTM3Y5Y
West Pharmaceutical Services, Inc. (WST)$24.79B55.4650.9960.1462.91
Waters Corporation (WAT)vs ›$24.41B116.4943.5840.5039.12
Mettler-Toledo International Inc. (MTD)vs ›$25.54B32.2931.3331.0335.87
Quest Diagnostics Incorporated (DGX)vs ›$23.23B17.7316.1618.1815.27
BioNTech SE (BNTX)vs ›$23.07B15.4333.2511.1014.34
United Therapeutics Corporation (UTHR)vs ›$23.03B25.1920.5318.0717.74
Moderna, Inc. (MRNA)vs ›$26.69BN/A28.0727.2327.23
Incyte Corporation (INCY)vs ›$22.73B16.2218.91108.0474.03
DexCom, Inc. (DXCM)vs ›$27.07B19.3134.4162.60175.28
Labcorp Holdings Inc. (LH)vs ›$22.26B16.2617.3019.6315.90

Free Cash Flow Valuation

P/FCF Ratio

55.5

FCF Yield

1.80%

Price/FCF Ratio Formula & Definition

P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Price/FCF Ratio FAQ

What is the Price/FCF ratio for West Pharmaceutical Services, Inc. (WST)?
The Price/FCF ratio for WST stock is 55.46.
Is West Pharmaceutical Services, Inc.'s Price/FCF ratio high or low?
The Price/FCF ratio of 55.46 is 16% below its 5-year average of 65.65, near the low end of its 5-year range (35.83–123.39).
What is the TTM average Price/FCF ratio for West Pharmaceutical Services, Inc. (WST)?
The TTM average Price/FCF ratio for WST stock is 50.99.
What is the 3Y average Price/FCF ratio for West Pharmaceutical Services, Inc. (WST)?
The 3Y average Price/FCF ratio for WST stock is 60.14.
What is the 5Y average Price/FCF ratio for West Pharmaceutical Services, Inc. (WST)?
The 5Y average Price/FCF ratio for WST stock is 62.91.
What is the 10Y average Price/FCF ratio for West Pharmaceutical Services, Inc. (WST)?
The 10Y average Price/FCF ratio for WST stock is 64.97.
What is the 15Y average Price/FCF ratio for West Pharmaceutical Services, Inc. (WST)?
The 15Y average Price/FCF ratio for WST stock is 60.83.
What is the 20Y average Price/FCF ratio for West Pharmaceutical Services, Inc. (WST)?
The 20Y average Price/FCF ratio for WST stock is 57.04.

WST Price/FCF Ratio History

DATEPRICE/FCF RATIO
2026-06-2655.46
2026-06-2554.78
2026-06-2453.81
2026-06-2353.18
2026-06-2252.12
2026-06-1851.84
2026-06-1751.15
2026-06-1652.10
2026-06-1552.39
2026-06-1251.98
2026-06-1152.22
2026-06-1052.31
2026-06-0952.90
2026-06-0850.55
2026-06-0549.72
2026-06-0450.16
2026-06-0350.00
2026-06-0249.35
2026-06-0150.00
2026-05-2951.03
2026-05-2850.87
2026-05-2749.43
2026-05-2649.98
2026-05-2250.02
2026-05-2149.97
2026-05-2048.29
2026-05-1948.04
2026-05-1848.12
2026-05-1547.88
2026-05-1447.45
2026-05-1347.80
2026-05-1249.33
2026-05-1150.95
2026-05-0851.52
2026-05-0750.90
2026-05-0649.41
2026-05-0549.00
2026-05-0447.45
2026-05-0147.53
2026-04-3047.04
2026-04-2946.69
2026-04-2846.18
2026-04-2747.77
2026-04-2448.40
2026-04-2348.96
2026-04-2242.55
2026-04-2142.59
2026-04-2043.10
2026-04-1742.44
2026-04-1641.83
2026-04-1541.32
2026-04-1441.54
2026-04-1340.31
2026-04-1039.78
2026-04-0940.09
2026-04-0841.23
2026-04-0740.21
2026-04-0639.82
2026-04-0239.51
2026-04-0139.19
2026-03-3138.86
2026-03-3038.01
2026-03-2737.73
2026-03-2638.47
2026-03-2538.30
2026-03-2438.03
2026-03-2337.43
2026-03-2036.75
2026-03-1937.26
2026-03-1837.06
2026-03-1737.12
2026-03-1637.26
2026-03-1336.51
2026-03-1235.83
2026-03-1136.94
2026-03-1036.25
2026-03-0938.46
2026-03-0638.12
2026-03-0537.88
2026-03-0438.58
2026-03-0338.97
2026-03-0238.95
2026-02-2739.43
2026-02-2638.61
2026-02-2538.43
2026-02-2438.04
2026-02-2337.86
2026-02-2037.38
2026-02-1937.80
2026-02-1838.49
2026-02-1737.71
2026-02-1348.04
2026-02-1246.72
2026-02-1147.21
2026-02-1046.71
2026-02-0947.74
2026-02-0647.74
2026-02-0544.42
2026-02-0445.46
2026-02-0344.29
2026-02-0245.55
2026-01-3044.32
2026-01-2944.62
2026-01-2845.24
2026-01-2746.13
2026-01-2646.29
2026-01-2345.38
2026-01-2247.52
2026-01-2148.93
2026-01-2048.04
2026-01-1649.82
2026-01-1553.58
2026-01-1452.73
2026-01-1352.13
2026-01-1252.34
2026-01-0952.84
2026-01-0852.78
2026-01-0753.40
2026-01-0653.82
2026-01-0553.51
2026-01-0253.01
2025-12-3152.76
2025-12-3053.10
2025-12-2952.85
2025-12-2652.60
2025-12-2453.06
2025-12-2353.21
2025-12-2252.72
2025-12-1952.26
2025-12-1851.52
2025-12-1751.61
2025-12-1651.10
2025-12-1552.13
2025-12-1251.31
2025-12-1152.26
2025-12-1051.19
2025-12-0951.02
2025-12-0851.60
2025-12-0553.74
2025-12-0454.04
2025-12-0354.52
2025-12-0252.36
2025-12-0152.57
2025-11-2853.17
2025-11-2653.15
2025-11-2553.86
2025-11-2452.54
2025-11-2151.98
2025-11-2049.43
2025-11-1949.46
2025-11-1849.89
2025-11-1750.32
2025-11-1450.12
2025-11-1351.14
2025-11-1252.52
2025-11-1153.20
2025-11-1052.83
2025-11-0751.98
2025-11-0652.80
2025-11-0554.37
2025-11-0455.03
2025-11-0353.65
2025-10-3154.09
2025-10-3053.42
2025-10-2954.63
2025-10-2854.36
2025-10-2755.08
2025-10-2457.05
2025-10-2358.92
2025-10-2258.62
2025-10-2159.13
2025-10-2058.18
2025-10-1757.27
2025-10-1656.54
2025-10-1555.65
2025-10-1455.27
2025-10-1355.55
2025-10-1055.40
2025-10-0955.78
2025-10-0856.70
2025-10-0756.29
2025-10-0656.73
2025-10-0357.68
2025-10-0257.81
2025-10-0157.44
2025-09-3055.52
2025-09-2955.09
2025-09-2655.34
2025-09-2553.86
2025-09-2455.01
2025-09-2353.08
2025-09-2253.38
2025-09-1953.93
2025-09-1853.96
2025-09-1754.31
2025-09-1654.67
2025-09-1554.50
2025-09-1253.65
2025-09-1155.81
2025-09-1054.01
2025-09-0953.34
2025-09-0853.57
2025-09-0553.06
2025-09-0452.39
2025-09-0352.68
2025-09-0251.58
2025-08-2952.26
2025-08-2851.94
2025-08-2752.05
2025-08-2651.74
2025-08-2552.32
2025-08-2252.45
2025-08-2151.35
2025-08-2052.14
2025-08-1952.27
2025-08-1851.44
2025-08-1552.10
2025-08-1452.10
2025-08-1352.11
2025-08-1250.77
2025-08-1150.86
2025-08-0851.00
2025-08-0750.90
2025-08-0650.22
2025-08-0550.55
2025-08-0450.45
2025-08-0150.63
2025-07-3150.63
2025-07-3052.74
2025-07-2953.53
2025-07-2854.55
2025-07-2555.77
2025-07-2459.07
2025-07-2354.07
2025-07-2252.07
2025-07-2149.97
2025-07-1850.16
2025-07-1752.71
2025-07-1653.37
2025-07-1552.58
2025-07-1453.40
2025-07-1154.04
2025-07-1054.53
2025-07-0953.80
2025-07-0852.44
2025-07-0752.68
2025-07-0352.87
2025-07-0252.62
2025-07-0152.91
2025-06-3052.04
2025-06-2752.06
2025-06-2652.09
2025-06-2552.57
2025-06-2452.97
2025-06-2351.54
2025-06-2051.34
2025-06-1851.84
2025-06-1751.87
2025-06-1653.35
2025-06-1352.78

Showing the most recent 260 of 4,526 data points. The chart above shows the full history.

About West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.

Exton, PA
10,600 employees
Healthcare / Medical - Instruments & Supplies
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Eric Green